The ATMI LifeSciences portfolio acquired by Pall includes custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors for the pharmaceutical and biopharmaceutical industries.
“The acquisition of ATMI LifeSciences broadens our upstream presence in bioprocessing and complements our established downstream capabilities,” said Larry Kingsley, Pall chairman and CEO. “Combined with the recent acquisitions of single-use innovators Medistad Holding BV and SoloHill Engineering Inc and our already solid portfolio of biopharmaceutical solutions, the addition of the ATMI LifeSciences assets positions us well to capitalize on opportunities in the rapidly growing single-use market segment.”